Palvella Therapeutics, Inc. (PVLA)

NASDAQ: PVLA · Real-Time Price · USD

149.97

-0.36 (-0.24%)

Aug 28, 2026, 4:00 PM EDT - Market closed

Palvella Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	187.8	57.98	83.6	7.35	16.05
Cash & Short-Term Investments	250.58	57.98	83.6	7.35	16.05
Cash Growth	255.78%	-30.64%	1037.44%	-54.21%	-
Accounts Receivable	-	-	0.36	-	-
Other Receivables	0.4	-	1.98	-	-
Receivables	0.4	-	2.34	-	-
Prepaid Expenses	2.04	1.01	2.3	0.2	0.47
Total Current Assets	253.03	58.99	88.23	7.55	16.52
Property, Plant & Equipment	0.48	0.57	-	-	-
Total Assets	253.51	59.56	88.23	7.55	16.52

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Accounts Payable	6.79	4.6	4.59	0.94	3.18
Accrued Expenses	3.7	3.65	4.29	1.26	2.44
Current Portion of Leases	0.22	0.2	-	-	-
Other Current Liabilities	1.24	2.9	3.17	0.17	0.16
Total Current Liabilities	11.95	11.34	12.04	2.36	5.78
Long-Term Debt	22.11	17.76	11.94	8.05	32.42
Long-Term Leases	0.32	0.43	-	-	-
Other Long-Term Liabilities	2.27	2.04	1.65	1.01	1.5
Total Liabilities	36.64	31.58	25.63	11.43	39.7

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Common Stock	0.01	0.01	0.01	-	-
Additional Paid-In Capital	389.85	163.34	156.33	1.82	1.22
Retained Earnings	-173.09	-135.45	-93.74	-76.3	-94.99
Comprehensive Income & Other	0.09	0.08	0	-	-
Total Common Equity	216.87	27.98	62.61	-74.48	-93.78
Shareholders' Equity	216.87	27.98	62.61	-3.88	-23.17
Total Liabilities & Equity	253.51	59.56	88.23	7.55	16.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Total Debt	22.64	18.39	11.94	8.05	32.42
Net Cash (Debt)	227.94	39.59	71.66	-0.7	-16.36
Net Cash Growth	307.61%	-44.75%	-	-	-
Net Cash Per Share	18.10	3.52	32.19	-0.39	-2.86
Filing Date Shares Outstanding	14.41	14.31	11.02	5.72	5.72
Total Common Shares Outstanding	14.4	12.38	11.01	5.72	5.72
Working Capital	241.08	47.64	76.2	5.19	10.74
Book Value Per Share	15.06	2.26	5.69	-13.02	-16.40
Tangible Book Value	216.87	27.98	62.61	-74.48	-93.78
Tangible Book Value Per Share	15.06	2.26	5.69	-13.02	-16.40

SEC Filings: 10-K · 10-Q